Clinical Trials Browser

OTHER × Interventional × pixantrone × Clear all

NCT03458260 2026-03-10

Study of Pixantrone in CD20+ Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma

Phase 2 Completed

Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT01491841 2020-03-04

BRP

Phase 1 Completed

33 enrolled 13 charts

Lymphoma, Non-Hodgkin